Document is current
Any future updates will be listed below
-
Authors
Tylden, Eline Sol
Delgado, André Berli
Lukic, Marko
Moi, Line
Busund, Lill-Tove Rasmussen
Pedersen, Mona Irene
Lombardi, Ana Paola
Olsen, Karina Standahl
-
Funding
Funding for this research was provided by:
UiT The Arctic University of Norway
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 7 October 2024
First Online: 23 October 2024
Declarations
:
: The authors declare no competing interests.
: This study was conducted in accordance with the Declaration of Helsinki. The Regional Ethical Committee (REK) of North Norway approved the NOWAC study and the study of miRNA expression in tumor samples from the NOWAC Post-genome cohort participants (REK nord 2010/1931, 2013/2271), including the use of clinical and questionnaire information, cancer tissue and storing of data. The NOWAC-participants gave written, informed consent at the time of inclusion to NOWAC, and they can withdraw from the study at any time. Participants may request that any collected samples and information be deleted. Storing of all relevant, not identifiable data, and the linkage to national registries have been approved by the Norwegian Data Protection Authority.
